Adverum Biotechnologies, Inc. Insider Trading for June 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adverum Biotechnologies, Inc. for June 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Whitcup Scott M | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Lupher, Jr. Mark L. | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Hemrajani Rekha | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 25 2020 | ADVM | Adverum Biotechnol ... | Carter Eric G | Director | Option Exercise | A | 25.64 | 30,000 | 769,200 | 30,000 | |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 23,605 | 113,304 | 83,000 | |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.06 | 23,605 | 591,617 | 274,442 | 298 K to 274.4 K (-7.92 %) |
| Jun 23 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 23,605 | 113,304 | 298,047 | 274.4 K to 298 K (+8.60 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 11,127 | 53,410 | 106,605 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 11,127 | 53,410 | 106,605 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 268 | 1,286 | 117,732 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 268 | 1,286 | 117,732 | |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 11,127 | 278,329 | 274,442 | 285.6 K to 274.4 K (-3.90 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 11,127 | 278,329 | 274,442 | 285.6 K to 274.4 K (-3.90 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 11,127 | 53,410 | 285,569 | 274.4 K to 285.6 K (+4.05 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 11,127 | 53,410 | 285,569 | 274.4 K to 285.6 K (+4.05 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 268 | 6,703 | 274,442 | 274.7 K to 274.4 K (-0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 25.01 | 268 | 6,703 | 274,442 | 274.7 K to 274.4 K (-0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 268 | 1,286 | 274,710 | 274.4 K to 274.7 K (+0.10 %) |
| Jun 18 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 268 | 1,286 | 274,710 | 274.4 K to 274.7 K (+0.10 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | PATTERSON LEONE D | President | Sell | S | 24.68 | 13,171 | 325,060 | 110,488 | 123.7 K to 110.5 K (-10.65 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | M | 4.80 | 10,000 | 48,000 | 118,000 | |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 23.59 | 159 | 3,751 | 274,442 | 274.6 K to 274.4 K (-0.06 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 23.00 | 3,425 | 78,787 | 274,601 | 278 K to 274.6 K (-1.23 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 21.93 | 1,416 | 31,047 | 278,026 | 279.4 K to 278 K (-0.51 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Sell | S | 21.01 | 5,000 | 105,042 | 279,442 | 284.4 K to 279.4 K (-1.76 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Buy | M | 4.80 | 10,000 | 48,000 | 284,442 | 274.4 K to 284.4 K (+3.64 %) |
| Jun 17 2020 | ADVM | Adverum Biotechnol ... | Fischer Laurent | CEO and Director | Option Exercise | A | 23.70 | 1,200,000 | 28,440,000 | 1,200,000 |